Hyperfine, Inc.(HYPR)Earnings, Financials & Key RatiosHyperfine, Inc. (HYPR) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate positive free cash flow, evidenced by consistent quarterly outflows often exceeding $8 million, presents a significant risk to long-term solvency.
Hyperfine, Inc. (HYPR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Hyperfine, Inc. (HYPR) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.09vs $0.09+0.0% | $4Mvs $4M+10.3% |
| Q2 2026 | Mar 18, 2026 | $0.08vs $0.08+0.0% | $5Mvs $5M+2.7% |
| Q4 2025 | Nov 13, 2025 | $0.11vs $0.10-10.0% | $3Mvs $5M-35.2% |
| Q3 2025 | Aug 13, 2025 | $0.12vs $0.12+0.0% | $3Mvs $3M-10.1% |
Recent stock market news and headlines for Hyperfine, Inc. (HYPR)
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine initiates the launch of the next-gen Swoop® system in Europe, beginning global expansion of its most advanced portable MRI technology. .
GUILFORD, Conn.--(BUSINESS WIRE)--Leading neurosurgeons will help guide the role of the Swoop® system in neurosurgical care, including workflow, product capabilities, and evidence.
[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powere
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces Swoop® system scan volume milestones at key hospitals and neurology clinics, demonstrating accelerating adoption across the US.
Key metrics vs top competitors for Hyperfine, Inc. (HYPR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.27 | $106.95M | -2.95 | 5.22% | -262.29% | -79.01% | — | |
| $21.21 | $1.21B | -12.33 | 37.22% | -31.82% | -27.7% | — | |
| $17.32 | $1.97B | -14.20 | 8.28% | -25.66% | -50.82% | — | |
| $21.82 | $1.61B | 6.61 | 18.52% | 118.91% | 47.59% | — | |
| $7.24 | $90.45M | -28.96 | 14.52% | -9.05% | -70.95% | — | |
| $64.84 | $29.5B | 14.25 | 4.84% | 7.54% | 14.45% | — |
Hyperfine, Inc. (HYPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Hyperfine, Inc. (HYPR) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 21, 2026·SEC
May 12, 2026·SEC
Mar 18, 2026·SEC
Get notified when HYPR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Hyperfine, Inc. (HYPR) stock FAQ — growth, dividends, profitability & financials explained
Hyperfine, Inc. (HYPR) reported $15.3M in revenue for fiscal year 2025.
Hyperfine, Inc. (HYPR) grew revenue by 5.2% over the past year. This is steady growth.
Hyperfine, Inc. (HYPR) reported a net loss of $34.8M for fiscal year 2025.
Hyperfine, Inc. (HYPR) has a return on equity (ROE) of -79.0%. Negative ROE indicates the company is unprofitable.
Hyperfine, Inc. (HYPR) had negative free cash flow of $28.7M in fiscal year 2025, likely due to heavy capital investments.
